Status | Study |
Terminated |
Study Name: Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) Condition: Non-small-cell Lung Cancer Date: 2012-01-12 Interventions: Radiation: SBRT (stereotactic body radiotherapy) |
Recruiting |
Study Name: A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment Condition: Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Date: 2011-12-14 Interventions: Drug: Docetaxel Docetaxel (dil |
Terminated |
Study Name: -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer Condition: Carcinoma, Non-Small Cell Lung Adenocarcinoma Carcinoma, S Date: 2011-09-24 Interventions: Drug: PF-02341066/PF-00299804 |
Completed |
Study Name: A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer Condition: Non Small Cell Lung Cancer Date: 2011-05-26 Interventions: Drug: IPI 504 plus Docetaxel |
Completed |
Study Name: RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation Condition: Carcinoma, Large Cell Neuroendocrine Tumors Date: 2011-03-16 Interventions: Drug: RAD001 Participants star |
Terminated |
Study Name: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer Condition: Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung Date: 2008-05-05 Interventions: Drug: CP 751,871 (Figitumumab) |
Terminated |
Study Name: Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) Condition: Carcinoma, Non-Small-Cell Lung Adenocarcinoma Date: 2008-02-29 Interventions: Drug: Temozolomide 5-mg, 20-mg, and 100-mg gel capsules, 75 mg/m^2 PO daily for 21 consecutive days, fol |
Terminated |
Study Name: Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology Condition: Carcinoma, Squamous Cell Carcinoma, Adenosquamous Date: 2008-01-03 Interventions: Drug: CP-751,871 (Figitumumab) |
Completed |
Study Name: ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures Condition: Non-Small-Cell Lung Carcinoma Date: 2006-11-28 Interventions: Drug: ZD6474 (vandetanib) once |
Terminated |
Study Name: Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer Condition: Non-Small Cell Lung Carcinoma Date: 2006-08-15 Interventions: Drug: Motexafin gadolinium and pemetrexed 1 dose of MGd 15 mg/kg and pemetrexed 500 mg/m2 once during th |